However, we also used immunocompetent BALB/c mice for in vivo studies with 4T1 cells; though those studies were limited by the aggressive nature of the model, the poor survival of animals receiving Il13ra2-deficient tumor cells suggests that immune interactions are not a critical modifier of the results. The gene discussed is IL13RA2; the disease is neoplasm.